Open mobile menu
Secerna Strengthens Expertise in Immunology and Cancer Therapeutics with New Trainee Patent Attorney

Secerna Strengthens Expertise in Immunology and Cancer Therapeutics with New Trainee Patent Attorney

News Team news Careers 14/12/2025

Secerna LLP is delighted to introduce Eleanor Graham as the newest member of our team. Eleanor specialises in intellectual property within the realm of life sciences, bringing her expertise to serve our global clientele.

Eleanor’s journey towards becoming a trainee patent attorney at Secerna is marked by a strong foundation in life sciences and a commitment to research and innovation. Her academic pursuits began at the University of Glasgow, where she earned a First Class Honours bachelor’s degree in Veterinary Biosciences. This foundation was further strengthened by an MSc in Applied Bioscience and Biotechnology, achieved with Distinction from Imperial College London, where her research focused on fibrosis mechanisms and the immune tumour microenvironment.

Following her master’s, Eleanor pursued a PhD in Cellular Biology at Newcastle University. Her doctoral research focused on investigating cellular senescence in the tumour immune microenvironment of hepatocellular carcinoma, applying senotherapeutics and gaining high proficiency in advanced laboratory protocols and data analysis. This in-depth research experience provides Eleanor with a unique understanding of the scientific principles underlying many life science innovations, particularly those related to cancer and immunology.

Eleanor said:

“I am thrilled to be joining Secerna, a firm renowned for its dedication to excellence in the life sciences sector. My extensive background in cellular biology and immunology research fuels my commitment to helping protect the vital innovations being developed, and I look forward to working alongside Charlotte and Secerna's expert team.”

 

Secerna Partner, Charlotte Watkins, stated:

“We are delighted to welcome Eleanor to our team. Her impressive academic background, especially her doctoral research into immunosenescence and cancer therapeutics, aligns perfectly with the complex needs of our life sciences clients. We are confident that Eleanor will be a valuable asset to our team and contribute significantly to the success of our clients.”

 

Secerna’s growth remains robust, and we are enthusiastic about attracting and nurturing talented individuals with a passion for intellectual property. We are committed to providing a supportive environment for trainees to develop their skills and contribute to the success of our clients.